For Canadian Residents Only
Understand the Risks of Meningococcal Meningitis
Get Adobe Flash Player
Sanofi Pasteur - The vaccines division of sanofi-aventis Group Get Adobe Flash Player
Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Welcome to menactra.ca, a website dedicated to inform you about meningococcal disease, including meningococcal meningitis, a rare but devastating condition that can begin suddenly and can lead to permanent disabilities or death, and how to help prevent it with MENACTRA®, a vaccine approved in Canada that helps protect against all 4 vaccine-preventable strains responsible for this challenging disease.

What to Expect on Menactra.ca

On this site, you will learn about the signs and symptoms
of meningococcal menigitis, the risk of getting infected,
who is most at risk and most important, how you can
help protect your family against this disease.
Left Red BracketFrançaisRight Red Bracket
 About Us  User Terms  Privacy Policy

 Contact Us  Sitemap  FOR U.S. RESIDENTS
Copyright © 2010 Sanofi Pasteur Limited.
MENACTRA® is a trademark of Sanofi Pasteur Limited.
This page last updated: 10-Mar-2010